Comorbidities Articles

In this retrospective cohort study of 18,910 patients, M. S. Jördens et al. examine a potential association between pulmonary hypertension and NAFLD and liver cirrhosis in an outpatient cohort in Germany. Their data suggests that incidence rates of NAFLD of NAFLD are significantly higher among patients with pulmonary ...

The aim of the present population-based cross-sectional study is to estimate the awareness of liver disease among patients with T2D and whether it differs according to the degree of liver fibrosis estimated by transient elastography. The authors included all patients with T2D that participated in the 2017-2018 cycle of the NHAHES Survey and underwent...

G. Pennisi et al. (Università di Palermo, Italy) aimed to evaluate the impact of fatty liver and fibrosis on cardiovascular risk in a general population. They recruited 542 subjects included in the community-based ABCD (Alimentazione, Benessere Cardiovascolare e Diabete) study...

Patients with T2DM and NAFLD exhibit higher risk of CVD compared with T2DM without NAFLD. In their review, C. Caussy et al. (Hopital Lyon Sud, France) underline that several studies have provided evidence that NAFLD could be an independent cardiovascular risk factor. A potential synergistic increase of cardiovascular risk between...

The prevalence of NAFLD in heart failure preserved left ventricular ejection fraction (HFpEF) patients could reach 50%. Therefore, NAFLD is considered an emerging risk factor. The purpose of this review by R. Itier et al. (Department of Cardiology, CHU, Toulouse, France) is to provide an overview of the relationships between NAFLD...

Diagnosis and management of extrahepatic manifestations of NAFLD are crucial for the treatment of these patients. These manifestations include cardiovascular disease, type 2 diabetes mellitus, metabolic syndrome, chronic kidney disease, obstructive sleep apnea, polycystic ovarian syndrome, hypothyroidism, psoriasis, and extrahepatic malignancy...

NAFLD has been reported to be associated with extrahepatic manifestations such as cardiovascular disease, T2DM, chronic kidney disease, extrahepatic malignancies, endocrine diseases, obstructive sleep apnea, and iron overload. Current data define a more complex relationship between NAFLD and T2DM than was previously believed...